Alerts in the last 24 hours

No Personalised Alerts!

To see personalised alerts you need to be logged in.

Log In

DENTSPLY International Inc Add to portfolio

NAS:XRAY, Jan 21, 04:49 UTC

Latest NAS:XRAY News

Filter your feed

Apply Filter

Saturday, January 19


News

DENTSPLY SHAREHOLDER ALERT: CLAIMSFILER REMINDS INVESTORS WITH LOSSES IN EXCESS OF $100,000 of Lead Plaintiff Deadline in Class Action Lawsuit Against Dentsply Sirona, Inc. - XRAY

XRAY

NEW ORLEANS, Jan. 18, 2019 /PRNewswire/ -- ClaimsFiler, a FREE shareholder information service, reminds investors that they have untilFebruary 19, 2019 to file lead plaintiff applications in a securities class action lawsuit against Dentsply Sirona, Inc. (XRAY), if they purchased the Company's shares between February 20, 2014 and August 7, 2018, inclusive (the "Class Period"). Dentsply and certain of its executives are charged with failing to disclose material information during the Class Period, violating federal securities laws. On August 7, 2018, the Company revealed a wide range of negative information to investors, including that it was the subject of an investigation by the Securities and Exchange Commission; that three of its top executives were stepping down; it was lowering its guidance, and it was recording a significant goodwill impairment charge. At ClaimsFiler.com, investors can: (1) register for free to gain access to information and settlement websites for various securities class action cases so they can timely submit their own claims; (2) upload their portfolio transactional data to be notified about relevant securities cases in which they may have a financial interest; and (3) submit inquiries to the Kahn Swick & Foti, LLC law firm for free case evaluations.

Read Full Details

Topics:
  • Business
  • Financial

Friday, January 18


News

SHAREHOLDER ALERT - Bronstein, Gewirtz & Grossman, LLC Reminds Investors of Class Action Against Dentsply Sirona, Inc. (XRAY) and Lead Plaintiff Deadline - February 19, 2019

XRAY

NEW YORK, Jan. 18, 2019 (GLOBE NEWSWIRE) -- Attorney Advertising -- Bronstein, Gewirtz & Grossman, LLC reminds investors that a class action lawsuit has been filed against Dentsply Sirona, Inc. ("Dentsply" or the "Company") (NASDAQ: XRAY) and certain of its officers, on behalf of shareholders who purchased or otherwise acquired Dentsply shares between February 20, 2014 through August 7, 2018, both dates inclusive (the “Class Period”). This class action seeks to recover damages against Defendants for alleged violations of the federal securities laws under the Securities Exchange Act of 1933 and the Securities Exchange Act of 1934. The complaint alleges that: (1) Dentsply was engaged in an anticompetitive scheme among its three primary distributors that suppressed competition and artificially inflated the price of Dentsply's products; and (2) Dentsply engaged in "channel-stuffing" which rendered the Company's reported sales, financial results and guidance materially false and misleading. A class action lawsuit has already been filed. If you wish to review a copy of the Complaint you can visit the firm’s site: bgandg.com/xray or you may contact Peretz Bronstein, Esq. or his Investor Relations Analyst, Yael Hurwitz of Bronstein, Gewirtz & Grossman, LLC at 212-697-6484. If you suffered a loss in Dentsply you have until February 19, 2019 to request that the Court appoint you as lead plaintiff.

Read Full Details

Topics:
  • Business
  • Financial

Saturday, January 12


News

DENTSPLY SHAREHOLDER ALERT by Former Louisiana Attorney General: Kahn Swick & Foti, LLC Reminds Investors with Losses in Excess of $100,000 of Lead Plaintiff Deadline in Class Action Lawsuit Against Dentsply Sirona, Inc. - XRAY

XRAY

Kahn Swick & Foti, LLC (“KSF”) and KSF partner, former Attorney General of Louisiana, Charles C. Foti, Jr., remind investors that they have until February 19, 2019 to file lead plaintiff applications in a securities class action lawsuit against Dentsply Sirona, Inc. (XRAY), if they purchased the Company’s shares between February 20, 2014 and August 7, 2018, inclusive (the “Class Period”). This action is pending in the United States District Court for the Eastern District of New York. What You May Do. If you purchased shares of Dentsply and would like to discuss your legal rights and how this case might affect you and your right to recover for your economic loss, you may, without obligation or cost to you, contact KSF Managing Partner Lewis Kahn toll-free at 1-877-515-1850 or via email (lewis.kahn@ksfcounsel.com), or visit https://www.ksfcounsel.com/cases/nasdaqgs-xray/ to learn more. If you wish to serve as a lead plaintiff in this class action, you must petition the Court by February 19, 2019. Dentsply and certain of its executives are charged with failing to disclose material information during the Class Period, violating federal securities laws. On August 7, 2018, the Company revealed a wide range of negative information to investors, including that it was the subject of an investigation by the Securities and Exchange Commission; that three of its top executives were stepping down; it was lowering its guidance, and it was recording a significant goodwill impairment charge.

Read Full Details

Topics:
  • Business
  • Financial

Friday, January 11


News

SHAREHOLDER ALERT: Bronstein, Gewirtz & Grossman, LLC Reminds Investors of Class Action Against Dentsply Sirona, Inc. (XRAY) and Lead Plaintiff Deadline: February 19, 2019

XRAY

NEW YORK, Jan. 11, 2019 (GLOBE NEWSWIRE) -- Attorney Advertising -- Bronstein, Gewirtz & Grossman, LLC reminds investors that a class action lawsuit has been filed against Dentsply Sirona, Inc. ("Dentsply" or the "Company") (NASDAQ: XRAY) and certain of its officers, on behalf of shareholders who purchased or otherwise acquired Dentsply shares between February 20, 2014through August 7, 2018, both dates inclusive (the “Class Period”). This class action seeks to recover damages against Defendants for alleged violations of the federal securities laws under the Securities Exchange Act of 1933 and the Securities Exchange Act of 1934. The complaint alleges that: (1) Dentsply was engaged in an anticompetitive scheme among its three primary distributors that suppressed competition and artificially inflated the price of Dentsply's products; and (2) Dentsply engaged in "channel-stuffing" which rendered the Company's reported sales, financial results and guidance materially false and misleading. A class action lawsuit has already been filed. If you wish to review a copy of the Complaint you can visit the firm’s site: bgandg.com/xray or you may contact Peretz Bronstein, Esq. or his Investor Relations Analyst, Yael Hurwitz of Bronstein, Gewirtz & Grossman, LLC at 212-697-6484. If you suffered a loss in Dentsply you have until February 19, 2019 to request that the Court appoint you as lead plaintiff.

Read Full Details

Topics:
  • Business
  • Financial

Thursday, January 10


News

INVESTOR ACTION REMINDER: The Schall Law Firm Announces the Filing of a Class Action Lawsuit Against Dentsply Sirona, Inc. Encourages Investors with Losses in Excess of $100,000 to Contact the Firm

XRAY

LOS ANGELES, Jan. 10, 2019 (GLOBE NEWSWIRE) -- The Schall Law Firm, a national shareholder rights litigation firm, announces the filing of a class action lawsuit against Dentsply Sirona, Inc. (“Dentsply” or “the Company”) (NASDAQ: XRAY) for violations of §§10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder by the U.S. Securities and Exchange Commission. Investors who purchased the Company's shares between February 20, 2014 and August 7, 2018, inclusive (the ''Class Period''), are encouraged to contact the firm before February 19, 2019. If you are a shareholder who suffered a loss, click here to participate. We also encourage you to contact Brian Schall, or Sherin Mahdavian, of the Schall Law Firm, 1880 Century Park East, Suite 404, Los Angeles, CA 90067, at 424-303-1964, to discuss your rights free of charge. The class, in this case, has not yet been certified, and until certification occurs, you are not represented by an attorney. If you choose to take no action, you can remain an absent class member.

Read Full Details

Topics:
  • Business
  • Financial

Saturday, January 05


News

DENTSPLY SHAREHOLDER ALERT: CLAIMSFILER Reminds Investors with Losses in Excess of $100,000 of Lead Plaintiff Deadline in Class Action Lawsuit Against Dentsply Sirona, Inc. - XRAY

XRAY

NEW ORLEANS, Jan. 04, 2019 (GLOBE NEWSWIRE) -- ClaimsFiler, a FREE shareholder information service, reminds investors that they have until February 19, 2019 to file lead plaintiff applications in a securities class action lawsuit against Dentsply Sirona, Inc. (XRAY), if they purchased the Company’s shares between February 20, 2014 and August 7, 2018, inclusive (the “Class Period”). Dentsply and certain of its executives are charged with failing to disclose material information during the Class Period, violating federal securities laws. On August 7, 2018, the Company revealed a wide range of negative information to investors, including that it was the subject of an investigation by the Securities and Exchange Commission; that three of its top executives were stepping down; it was lowering its guidance, and it was recording a significant goodwill impairment charge. At ClaimsFiler.com, investors can: (1) register for free to gain access to information and settlement websites for various securities class action cases so they can timely submit their own claims; (2) upload their portfolio transactional data to be notified about relevant securities cases in which they may have a financial interest; and (3) submit inquiries to the Kahn Swick & Foti, LLC law firm for free case evaluations.

Read Full Details

Topics:
  • Business
  • Financial

Thursday, January 03


News

SHAREHOLDER ALERT: Bronstein, Gewirtz & Grossman, LLC Reminds Investors of Class Action Against Dentsply Sirona, Inc. (XRAY) and Lead Plaintiff Deadline: February 19, 2019

XRAY

NEW YORK, Jan. 03, 2019 (GLOBE NEWSWIRE) -- Attorney Advertising -- Bronstein, Gewirtz & Grossman, LLC reminds investors that a class action lawsuit has been filed against Dentsply Sirona, Inc. ("Dentsply" or the "Company") (NASDAQ: XRAY) and certain of its officers, on behalf of shareholders who purchased or otherwise acquired Dentsply shares between February 20, 2014through August 7, 2018, both dates inclusive (the “Class Period”). This class action seeks to recover damages against Defendants for alleged violations of the federal securities laws under the Securities Exchange Act of 1933 and the Securities Exchange Act of 1934. The complaint alleges that: (1) Dentsply was engaged in an anticompetitive scheme among its three primary distributors that suppressed competition and artificially inflated the price of Dentsply's products; and (2) Dentsply engaged in "channel-stuffing" which rendered the Company's reported sales, financial results and guidance materially false and misleading. A class action lawsuit has already been filed. If you wish to review a copy of the Complaint you can visit the firm’s site: bgandg.com/xray or you may contact Peretz Bronstein, Esq. or his Investor Relations Analyst, Yael Hurwitz of Bronstein, Gewirtz & Grossman, LLC at 212-697-6484. If you suffered a loss in Dentsply you have until February 19, 2019 to request that the Court appoint you as lead plaintiff.

Read Full Details

Topics:
  • Business
  • Financial

Wednesday, January 02


News

3 Stock Charts for Wednesday: Dentsply, Procter & Gamble and Valero Energy

XRAY VLO +1 more XRAY VLO PG

Not far behind was the 3.6% pop from Advanced Micro Devices (NASDAQ:AMD), for no other discernible reason than traders wanted to start the new year with the popular stock already in-hand. WTW was off to the tune of 6.6% not on any specific news, but rather, as traders ultimately decided to dump the poorly performing stock as a means of securing a tax loss in 2018. Stock charts of Valero Energy (NYSE:VLO), Procter & Gamble (NYSE:PG) and Dentsply (NASDAQ:XRAY), however, look likely they’ve already charted a course as the new year kicks off. It has got more to do with the overall energy sector’s recent past and plausible future. But, of all the names that could rebound as oil prices turnaround — or at least stabilize — Valero Energy is better positioned than most. And, as of Monday’s close, VLO has cleared a hurdle that few were watching all that closely.

Read Full Details

Topics:
  • Business
  • Financial

Tuesday, January 01


News

DENTSPLY SIRONA Inc (XRAY) Expected to Announce Quarterly Sales of $1.01 Billion – Fairfield Current

XRAY

On average, analysts expect that DENTSPLY SIRONA will report full-year sales of $3.94 billion for the current financial year, with estimates ranging from $3.88 billion to $3.97 billion. For the next financial year, analysts forecast that the firm will post sales of $3.99 billion, with estimates ranging from $3.89 billion to $4.08 billion. The medical instruments supplier reported $0.38 EPS for the quarter, missing the consensus estimate of $0.46 by ($0.08). DENTSPLY SIRONA had a positive return on equity of 8.68% and a negative net margin of 41.97%. Atlanta Capital Management Co. L L C now owns 4,754,247 shares of the medical instruments supplier’s stock valued at $179,425,000 after purchasing an additional 18,007 shares during the last quarter.

Read Full Details

Topics:
  • Business
  • Financial

Saturday, December 29


News

DENTSPLY SHAREHOLDER ALERT BY FORMER LOUISIANA ATTORNEY GENERAL: KAHN SWICK & FOTI, LLC REMINDS INVESTORS WITH LOSSES IN EXCESS OF $100,000 of Lead Plaintiff Deadline in Class Action Lawsuit Against Dentsply Sirona, Inc. - XRAY

XRAY

NEW ORLEANS, Dec. 28, 2018 /PRNewswire/ -- Kahn Swick & Foti, LLC ("KSF") and KSF partner, former Attorney General of Louisiana, Charles C. Foti, Jr., remind investors that they have untilFebruary 19, 2019 to file lead plaintiff applications in a securities class action lawsuit against Dentsply Sirona, Inc. (XRAY), if they purchased the Company's shares between February 20, 2014 and August 7, 2018, inclusive (the "Class Period"). This action is pending in the United States District Court for the Eastern District of New York. What You May Do. If you purchased shares of Dentsply and would like to discuss your legal rights and how this case might affect you and your right to recover for your economic loss, you may, without obligation or cost to you, contact KSF Managing Partner Lewis Kahn toll-free at 1-877-515-1850 or via email (lewis.kahn@ksfcounsel.com), or visit https://www.ksfcounsel.com/cases/nasdaqgs-xray/ to learn more. If you wish to serve as a lead plaintiff in this class action, you must petition the Court by February 19, 2019. Dentsply and certain of its executives are charged with failing to disclose material information during the Class Period, violating federal securities laws. KSF, whose partners include the former Louisiana Attorney General Charles C. Foti, Jr., is a law firm focused on securities, antitrust and consumer class actions, along with merger & acquisition and breach of fiduciary litigation against publicly traded companies on behalf of shareholders.

Read Full Details

Topics:
  • Business
  • Financial
  • Science